Chiesi Group, a research-oriented international biopharmaceutical group, has officially launched The Impulse, an innovation platform designed to “accelerate bold ideas and meaningful partnerships in healthcare.”   The Impulse aims to tackle some of the biggest challenges facing patients, the planet, and people today by addressing not only healthcare symptoms but also the root causes of these challenges, such as climate change and access to care.   By creating a collaborative space for resear...